Evaluation  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
a  ||| S:14 E:16 ||| DT
hydrophilic  ||| S:16 E:28 ||| JJ
gingival  ||| S:28 E:37 ||| JJ
dental  ||| S:37 E:44 ||| JJ
sealant  ||| S:44 E:52 ||| NN
in  ||| S:52 E:55 ||| IN
beagle  ||| S:55 E:62 ||| JJ
dogs  ||| S:62 E:67 ||| NNS
A  ||| S:67 E:69 ||| DT
liquid  ||| S:69 E:76 ||| JJ
solution ||| S:76 E:84 ||| NN
,  ||| S:84 E:86 ||| ,
gingival  ||| S:86 E:95 ||| JJ
sealant  ||| S:95 E:103 ||| NNS
containing  ||| S:103 E:114 ||| VBG
polymers  ||| S:114 E:123 ||| NNS
that  ||| S:123 E:128 ||| WDT
form  ||| S:128 E:133 ||| VBP
a  ||| S:133 E:135 ||| DT
barrier  ||| S:135 E:143 ||| NN
film  ||| S:143 E:148 ||| NN
upon  ||| S:148 E:153 ||| IN
application  ||| S:153 E:165 ||| NN
was  ||| S:165 E:169 ||| VBD
evaluated  ||| S:169 E:179 ||| VBN
in  ||| S:179 E:182 ||| IN
dogs ||| S:182 E:186 ||| NNS
.  ||| S:186 E:188 ||| .
It  ||| S:188 E:191 ||| PRP
is  ||| S:191 E:194 ||| VBZ
a  ||| S:194 E:196 ||| DT
non-toxic ||| S:196 E:205 ||| JJ
,  ||| S:205 E:207 ||| ,
low  ||| S:207 E:211 ||| JJ
viscosity ||| S:211 E:220 ||| NN
,  ||| S:220 E:222 ||| ,
hydrophilic  ||| S:222 E:234 ||| JJ
barrier  ||| S:234 E:242 ||| NN
sealant  ||| S:242 E:250 ||| NN
that  ||| S:250 E:255 ||| IN
dries  ||| S:255 E:261 ||| NN
in  ||| S:261 E:264 ||| IN
approximately  ||| S:264 E:278 ||| RB
10  ||| S:278 E:281 ||| CD
to  ||| S:281 E:284 ||| TO
15-seconds  ||| S:284 E:295 ||| CD
after  ||| S:295 E:301 ||| IN
subgingival  ||| S:301 E:313 ||| JJ
application ||| S:313 E:324 ||| NN
.  ||| S:324 E:326 ||| .
It  ||| S:326 E:329 ||| PRP
was  ||| S:329 E:333 ||| VBD
designed  ||| S:333 E:342 ||| VBN
as  ||| S:342 E:345 ||| IN
a  ||| S:345 E:347 ||| DT
preventative  ||| S:347 E:360 ||| NN
to  ||| S:360 E:363 ||| TO
be  ||| S:363 E:366 ||| VB
applied  ||| S:366 E:374 ||| VBN
immediately  ||| S:374 E:386 ||| RB
following  ||| S:386 E:396 ||| VBG
a  ||| S:396 E:398 ||| DT
professional  ||| S:398 E:411 ||| JJ
oral  ||| S:411 E:416 ||| JJ
hygiene  ||| S:416 E:424 ||| JJ
procedure  ||| S:424 E:434 ||| NN
in  ||| S:434 E:437 ||| IN
order  ||| S:437 E:443 ||| NN
to  ||| S:443 E:446 ||| TO
block  ||| S:446 E:452 ||| VB
plaque  ||| S:452 E:459 ||| NNS
and  ||| S:459 E:463 ||| CC
calculus  ||| S:463 E:472 ||| JJ
formation  ||| S:472 E:482 ||| NN
in  ||| S:482 E:485 ||| IN
the  ||| S:485 E:489 ||| DT
sulcus  ||| S:489 E:496 ||| NN
and  ||| S:496 E:500 ||| CC
aid  ||| S:500 E:504 ||| NN
in  ||| S:504 E:507 ||| IN
the  ||| S:507 E:511 ||| DT
prevention  ||| S:511 E:522 ||| NN
of  ||| S:522 E:525 ||| IN
periodontal  ||| S:525 E:537 ||| JJ
disease  ||| S:537 E:545 ||| NN
in  ||| S:545 E:548 ||| IN
companion  ||| S:548 E:558 ||| NN
animals ||| S:558 E:565 ||| NNS
.  ||| S:565 E:567 ||| .
Additionally ||| S:567 E:579 ||| RB
,  ||| S:579 E:581 ||| ,
the  ||| S:581 E:585 ||| DT
polymer  ||| S:585 E:593 ||| NN
was  ||| S:593 E:597 ||| VBD
designed  ||| S:597 E:606 ||| VBN
to  ||| S:606 E:609 ||| TO
promote  ||| S:609 E:617 ||| VB
an  ||| S:617 E:620 ||| DT
aerobic  ||| S:620 E:628 ||| JJ
environment  ||| S:628 E:640 ||| NN
in  ||| S:640 E:643 ||| IN
the  ||| S:643 E:647 ||| DT
sulcus  ||| S:647 E:654 ||| NN
by  ||| S:654 E:657 ||| IN
oxygen  ||| S:657 E:664 ||| NN
and  ||| S:664 E:668 ||| CC
water  ||| S:668 E:674 ||| NN
transport  ||| S:674 E:684 ||| NN
through  ||| S:684 E:692 ||| IN
engineered  ||| S:692 E:703 ||| JJ
pores  ||| S:703 E:709 ||| NN
within  ||| S:709 E:716 ||| IN
the  ||| S:716 E:720 ||| DT
polymer ||| S:720 E:727 ||| NN
.  ||| S:727 E:729 ||| .
A  ||| S:729 E:731 ||| DT
30-day  ||| S:731 E:738 ||| JJ
split-mouth ||| S:738 E:749 ||| NN
,  ||| S:749 E:751 ||| ,
blinded  ||| S:751 E:759 ||| JJ
study  ||| S:759 E:765 ||| NN
in  ||| S:765 E:768 ||| IN
two  ||| S:768 E:772 ||| CD
groups  ||| S:772 E:779 ||| NNS
of  ||| S:779 E:782 ||| IN
15  ||| S:782 E:785 ||| CD
beagle  ||| S:785 E:792 ||| CD
dogs  ||| S:792 E:797 ||| NNS
was  ||| S:797 E:801 ||| VBD
used ||| S:801 E:805 ||| VBN
.  ||| S:805 E:807 ||| .
Plaque  ||| S:807 E:814 ||| NNP
was  ||| S:814 E:818 ||| VBD
significantly  ||| S:818 E:832 ||| RB
( ||| S:832 E:833 ||| -LRB-
p  ||| S:833 E:835 ||| CD
< ||| S:835 E:837 ||| SYM
0.05 ||| S:837 E:841 ||| CD
)  ||| S:841 E:843 ||| -RRB-
reduced  ||| S:843 E:851 ||| VBN
on  ||| S:851 E:854 ||| IN
the  ||| S:854 E:858 ||| DT
side  ||| S:858 E:863 ||| NN
receiving  ||| S:863 E:873 ||| VBG
the  ||| S:873 E:877 ||| DT
sealant  ||| S:877 E:885 ||| NN
by  ||| S:885 E:888 ||| IN
30.0 ||| S:888 E:892 ||| CD
%  ||| S:892 E:894 ||| NN
and  ||| S:894 E:898 ||| CC
50.5 ||| S:898 E:902 ||| CD
%  ||| S:902 E:904 ||| NN
( ||| S:904 E:905 ||| -LRB-
average  ||| S:905 E:913 ||| NN
=  ||| S:913 E:915 ||| SYM
40.3 ||| S:915 E:919 ||| CD
% ||| S:919 E:920 ||| NN
)  ||| S:920 E:922 ||| -RRB-
in  ||| S:922 E:925 ||| IN
groups  ||| S:925 E:932 ||| NNS
1  ||| S:932 E:934 ||| CD
and  ||| S:934 E:938 ||| CC
2 ||| S:938 E:939 ||| CD
,  ||| S:939 E:941 ||| ,
respectively ||| S:941 E:953 ||| RB
.  ||| S:953 E:955 ||| .
Calculus  ||| S:955 E:964 ||| NNP
was  ||| S:964 E:968 ||| VBD
significantly  ||| S:968 E:982 ||| RB
( ||| S:982 E:983 ||| -LRB-
p  ||| S:983 E:985 ||| CD
< ||| S:985 E:987 ||| SYM
0.05 ||| S:987 E:991 ||| CD
)  ||| S:991 E:993 ||| -RRB-
reduced  ||| S:993 E:1001 ||| VBN
on  ||| S:1001 E:1004 ||| IN
the  ||| S:1004 E:1008 ||| DT
side  ||| S:1008 E:1013 ||| NN
receiving  ||| S:1013 E:1023 ||| VBG
the  ||| S:1023 E:1027 ||| DT
sealant  ||| S:1027 E:1035 ||| NN
by  ||| S:1035 E:1038 ||| IN
27.2 ||| S:1038 E:1042 ||| CD
%  ||| S:1042 E:1044 ||| NN
and  ||| S:1044 E:1048 ||| CC
20.0 ||| S:1048 E:1052 ||| CD
%  ||| S:1052 E:1054 ||| NN
( ||| S:1054 E:1055 ||| -LRB-
average  ||| S:1055 E:1063 ||| NN
=  ||| S:1063 E:1065 ||| SYM
23.6 ||| S:1065 E:1069 ||| CD
% ||| S:1069 E:1070 ||| NN
)  ||| S:1070 E:1072 ||| -RRB-
in  ||| S:1072 E:1075 ||| IN
groups  ||| S:1075 E:1082 ||| NNS
1  ||| S:1082 E:1084 ||| CD
and  ||| S:1084 E:1088 ||| CC
2 ||| S:1088 E:1089 ||| CD
,  ||| S:1089 E:1091 ||| ,
respectively ||| S:1091 E:1103 ||| RB
.  ||| S:1103 E:1105 ||| .
Gingival  ||| S:1105 E:1114 ||| JJ
inflammation  ||| S:1114 E:1127 ||| NN
was  ||| S:1127 E:1131 ||| VBD
monitored  ||| S:1131 E:1141 ||| VBN
to  ||| S:1141 E:1144 ||| TO
assess  ||| S:1144 E:1151 ||| VB
product  ||| S:1151 E:1159 ||| NN
safety ||| S:1159 E:1165 ||| NN
.  ||| S:1165 E:1167 ||| .
Sides  ||| S:1167 E:1173 ||| NNS
receiving  ||| S:1173 E:1183 ||| VBG
sealant  ||| S:1183 E:1191 ||| NNS
showed  ||| S:1191 E:1198 ||| VBD
no  ||| S:1198 E:1201 ||| DT
statistically  ||| S:1201 E:1215 ||| JJ
significant  ||| S:1215 E:1227 ||| JJ
differences  ||| S:1227 E:1239 ||| NNS
in  ||| S:1239 E:1242 ||| IN
gingival  ||| S:1242 E:1251 ||| JJ
index  ||| S:1251 E:1257 ||| NN
score ||| S:1257 E:1262 ||| NN
.  ||| S:1262 E:1264 ||| .
No  ||| S:1264 E:1267 ||| DT
adverse  ||| S:1267 E:1275 ||| JJ
events  ||| S:1275 E:1282 ||| NNS
were  ||| S:1282 E:1287 ||| VBD
observed  ||| S:1287 E:1296 ||| VBN
in  ||| S:1296 E:1299 ||| IN
the  ||| S:1299 E:1303 ||| DT
study ||| S:1303 E:1308 ||| NN
.  ||| S:1308 E:1310 ||| .
This  ||| S:1310 E:1315 ||| DT
study  ||| S:1315 E:1321 ||| NN
demonstrates  ||| S:1321 E:1334 ||| VBZ
that  ||| S:1334 E:1339 ||| IN
this  ||| S:1339 E:1344 ||| DT
gingival  ||| S:1344 E:1353 ||| JJ
sealant  ||| S:1353 E:1361 ||| NN
can  ||| S:1361 E:1365 ||| MD
be  ||| S:1365 E:1368 ||| VB
used  ||| S:1368 E:1373 ||| VBN
as  ||| S:1373 E:1376 ||| IN
another  ||| S:1376 E:1384 ||| DT
valuable  ||| S:1384 E:1393 ||| JJ
tool  ||| S:1393 E:1398 ||| NN
for  ||| S:1398 E:1402 ||| IN
aiding  ||| S:1402 E:1409 ||| VBG
in  ||| S:1409 E:1412 ||| IN
the  ||| S:1412 E:1416 ||| DT
prevention  ||| S:1416 E:1427 ||| NN
of  ||| S:1427 E:1430 ||| IN
periodontal  ||| S:1430 E:1442 ||| JJ
disease  ||| S:1442 E:1450 ||| NN
in  ||| S:1450 E:1453 ||| IN
dogs ||| S:1453 E:1457 ||| NNS
.  ||| S:1457 E:1459 ||| .
